CAS: 13269-35-7 - R-(+)-Hyoscyamine
Formula:C17H23NO3
InChI:InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m0/s1
InChI key:InChIKey=RKUNBYITZUJHSG-JJXSEGSLSA-N
SMILES:O=C(OC1CC2N(C)C(CC2)C1)C(C=3C=CC=CC3)CO
- Synonyms:
- (+)-Atropine
- (+)-Hyoscyamine
- (R)-Atropine
- 8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2R)-3-hydroxy-2-phenylpropanoate
- <span class="text-smallcaps">D</span>-Hyoscyamine
- Benzeneacetic acid, α-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (αR)-
- Benzeneacetic acid, α-(hydroxymethyl)-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, [3(R)-endo]-
- d-Atropine
- d-Hyoscyamine
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
D-Atropine-d5 REF: 4Z-A-151030CAS: 13269-35-7 | - - - | To inquire | Tue 14 Jan 25 | |
D-Atropine REF: 4Z-A-151029CAS: 13269-35-7 | - - - | To inquire | Tue 14 Jan 25 | |
D-Hyoscyamine REF: TR-H674303CAS: 13269-35-7 | - - - | 2,167.00 € | Tue 18 Feb 25 | |
D-Hyoscyamine REF: 3D-NAA26935CAS: 13269-35-7 | Min. 95% | To inquire | Tue 01 Apr 25 |
Ref: 4Z-A-151030
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 4Z-A-151029
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
D-Hyoscyamine
Controlled ProductCAS:13269-35-7
Formula:
C17H23NO3
Color and Shape:
Neat
Molecular weight:
289.369
Ref: TR-H674303
25mg | 2,167.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
D-Hyoscyamine
CAS:13269-35-7
D-Hyoscyamine is a potent anticancer agent that has been shown to induce apoptosis in cancer …
Formula:
C17H23NO3
Purity:
Min. 95%
Molecular weight:
289.4 g/mol
Ref: 3D-NAA26935
10mg | 2,898.00 € | ||
25mg | 3,478.00 € | ||
50mg | 4,405.00 € | ||
100mg | 4,869.00 € |
Estimated delivery in United States, on Tuesday 1 Apr 2025